EGFR in Enamel Matrix Derivative-induced gingival fibroblast mitogenesis

Area of Science:

• Cell Biology
• Biochemistry
• Dermatology

Background:

• Enamel Matrix Derivative (EMD) is known to induce proliferation of human gingival fibroblasts.
• Extracellular Regulated Kinase (ERK) activation is a key pathway involved in this proliferative response.
• The potential role of Epidermal Growth Factor Receptor (EGFR) in mediating EMD's effects remained to be elucidated.

Purpose of the Study:

• To investigate the involvement of EGFR in EMD-induced proliferation of human gingival fibroblasts.
• To determine the signaling pathways linking EMD to EGFR activation and subsequent fibroblast proliferation.

Main Methods:

• Human gingival fibroblasts were treated with EMD.
• EGFR tyrosine phosphorylation was assessed using immunoblotting and ELISA.
• The effects of specific EGFR tyrosine kinase inhibitors and metalloproteinase inhibitors were evaluated.
• The role of Src family kinases was examined using PP1 inhibitor.

Main Results:

• EMD treatment led to tyrosine phosphorylation of EGFR.
• EGFR inhibition significantly reduced EMD-induced ERK activation and thymidine incorporation (40-50%).
• EMD-induced EGFR activation was attributed to metalloproteinase-mediated shedding of Heparin-binding EGF (HB-EGF).
• PP1, a Src family inhibitor, blocked both EGFR phosphorylation and ERK activation.

Conclusions:

• EMD-induced proliferation of human gingival fibroblasts is partially mediated by EGFR transactivation.
• This EGFR transactivation is dependent on Src family kinases and involves metalloproteinase-mediated HB-EGF shedding.
• The findings elucidate a novel signaling mechanism for EMD in fibroblast biology.